{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:10:13Z","timestamp":1794035413439,"version":"4.8.0"},"reference-count":493,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM149665"],"award-info":[{"award-number":["R01GM149665"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharmr.2024.100023","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T11:19:09Z","timestamp":1733743149000},"page":"100023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms"],"prefix":"10.1016","volume":"77","author":[{"given":"Bruno","family":"Hagenbuch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar P.","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2024.100023_bib1","doi-asserted-by":"crossref","first-page":"22395","DOI":"10.1074\/jbc.273.35.22395","article-title":"Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2","volume":"273","author":"Abe","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib2","doi-asserted-by":"crossref","first-page":"17159","DOI":"10.1074\/jbc.274.24.17159","article-title":"Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1","volume":"274","author":"Abe","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-5347(25)00086-2","article-title":"On the pharmacological action of some phthaleins and their derivatives, with especial reference to their behavior as purgatives. I","volume":"1","author":"Abel","year":"1909","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2024.100023_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cpt.2102","article-title":"Liquid biopsy enables quantification of the abundance and interindividual variability of hepatic enzymes and transporters","volume":"109","author":"Achour","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/pgs.13.60","article-title":"GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis","volume":"14","author":"Acosta-Colman","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib7","doi-asserted-by":"crossref","first-page":"F1188","DOI":"10.1152\/ajprenal.00402.2002","article-title":"Molecular characterization of human and rat organic anion transporter OATP-D","volume":"285","author":"Adachi","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1124\/dmd.109.028654","article-title":"Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs","volume":"37","author":"Ahlin","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bja.2021.01.029","article-title":"First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2","volume":"126","author":"Ahlstrom","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pharmr.2024.100023_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aav7102","article-title":"Structural insight into substrate and inhibitor discrimination by human P-glycoprotein","volume":"363","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2024.100023_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186924","article-title":"Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner","volume":"12","author":"Alam","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bcp.15990","article-title":"Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: impact on pharmacokinetics and drug-drug interactions","volume":"90","author":"Armani","year":"2024","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 7","key":"10.1016\/j.pharmr.2024.100023_bib13","first-page":"S205","article-title":"Effect of disease pathologies on transporter expression and function","volume":"56","author":"Atilano-Roque","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib14","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/febs.15156","article-title":"A\u00a0novel fluorescence-based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third-generation P-gp inhibitors and OATP1A2","volume":"287","author":"Bakos","year":"2020","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2024.100023_bib15","first-page":"10","article-title":"Membrane protein quantification by peptide-based mass spectrometry approaches: studies on the organic anion-transporting polypetide family","volume":"6","author":"Balogh","year":"2013","journal-title":"J\u00a0Proteomics Bioinform"},{"key":"10.1016\/j.pharmr.2024.100023_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.112.192344","article-title":"Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells","volume":"342","author":"Banerjee","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90143-4","article-title":"Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p","volume":"11","author":"Barbier","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib18","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1200\/JCO.2006.06.5946","article-title":"Commonly used imaging techniques for diagnosis and staging","volume":"24","author":"Barentsz","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pharmr.2024.100023_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.118.253062","article-title":"Comprehensive evaluation of the utility of 20 endogenous molecules as biomarkers of OATP1B inhibition compared with rosuvastatin and coproporphyrin I","volume":"368","author":"Barnett","year":"2019","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0005-2736(85)90344-X","article-title":"Effects of membrane-potential and surface-potential on the kinetics of solute transport","volume":"813","author":"Barts","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cpt.888","article-title":"Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography","volume":"104","author":"Bauer","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2010.06.012","article-title":"Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3","volume":"405","author":"Bednarczyk","year":"2010","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharmr.2024.100023_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00498254.2015.1085111","article-title":"Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III","volume":"46","author":"Bednarczyk","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmr.2024.100023_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1124\/dmd.112.050500","article-title":"Variability in P-glycoprotein inhibitory potency (IC50) using various in\u00a0vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria","volume":"41","author":"Bentz","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1345\/aph.1E614","article-title":"Transporters and their impact on drug disposition","volume":"39","author":"Beringer","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmr.2024.100023_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.1840070131","article-title":"Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions","volume":"7","author":"Berk","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics14040789","article-title":"Magnitude of drug-drug interactions in special populations","volume":"14","author":"Bettonte","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2024.100023_bib28","series-title":"Gastroenterology in the 20th Century","first-page":"267","article-title":"Bile: a historical review of studies on its form and function","author":"Beuers","year":"1994"},{"key":"10.1016\/j.pharmr.2024.100023_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/dmd.120.000134","article-title":"Effect of human plasma on hepatic uptake of organic anion-transporting polypeptide 1B substrates: studies using transfected cells and primary human hepatocytes","volume":"49","author":"Bi","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib30","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1371\/journal.pbio.0020247","article-title":"Genomic analysis of mouse retinal development","volume":"2","author":"Blackshaw","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-3565(25)12411-7","article-title":"Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver","volume":"276","author":"Bossuyt","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0168-8278(96)80246-7","article-title":"Multispecific amphipathic substrate transport by an organic anion transporter of human liver","volume":"25","author":"Bossuyt","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/dmd.119.088948","article-title":"Changes in organic anion transporting polypeptide uptake in HEK293 overexpressing cells in the presence and absence of human plasma","volume":"48","author":"Bowman","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.ph.54.030192.002215","article-title":"Hepatic transport systems regulating pHi, cell volume, and bile secretion","volume":"54","author":"Boyer","year":"1992","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib35","doi-asserted-by":"crossref","first-page":"30326","DOI":"10.1074\/jbc.M602048200","article-title":"OATP8\/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?","volume":"281","author":"Briz","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/bj20030034","article-title":"Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin","volume":"371","author":"Briz","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2024.100023_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.2013.81","article-title":"In\u00a0vitro methods to support transporter evaluation in drug discovery and development","volume":"94","author":"Brouwer","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cpt.2605","article-title":"Regulation of drug transport proteins-from mechanisms to clinical impact: a white paper on behalf of the International Transporter Consortium","volume":"112","author":"Brouwer","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-biophys-070816-033843","article-title":"Soft matter in lipid-protein interactions","volume":"46","author":"Brown","year":"2017","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.pharmr.2024.100023_bib40","doi-asserted-by":"crossref","first-page":"G702","DOI":"10.1152\/ajpgi.00458.2001","article-title":"An evolutionarily ancient Oatp: insights into conserved functional domains of these proteins","volume":"282","author":"Cai","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/019262339502300202","article-title":"An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion","volume":"23","author":"Caldwell","year":"1995","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.pharmr.2024.100023_bib42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0014-5793(00)01596-9","article-title":"Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver","volume":"474","author":"Cattori","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmr.2024.100023_bib43","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.xphs.2021.05.018","article-title":"Impact of changes in free concentrations and drug-protein binding on drug dosing regimens in special populations and disease states","volume":"110","author":"Celestin","year":"2021","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib44","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1113\/jphysiol.2011.207290","article-title":"The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation","volume":"589","author":"Chan","year":"2011","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/dmd.105.003640","article-title":"Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps)","volume":"33","author":"Cheng","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2125.2011.04123.x","article-title":"Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients","volume":"73","author":"Chew","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib47","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1124\/dmd.31.11.1337","article-title":"Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats","volume":"31","author":"Choudhuri","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/bbrc.2000.4072","article-title":"Cloning, expression, and ontogeny of mouse organic anion-transporting polypeptide-5, a kidney-specific organic anion transporter","volume":"280","author":"Choudhuri","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the International Transporter Consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/cpt.2643","article-title":"Clinical implications of altered drug transporter abundance\/function and PBPK modeling in specific populations: an ITC perspective","volume":"112","author":"Chu","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib52","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.106.116517","article-title":"Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein","volume":"321","author":"Chu","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcp.2017.02.013","article-title":"The N-terminal region of organic anion transporting polypeptide 1B3 (OATP1B3) plays an essential role in regulating its plasma membrane trafficking","volume":"131","author":"Chun","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib54","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/s41467-023-41552-8","article-title":"Structure of human drug transporters OATP1B1 and OATP1B3","volume":"14","author":"Ciuta","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1152\/ajplegacy.1973.225.1.192","article-title":"Shared and separate pathways for biliary excretion of bilirubin and BSP in rats","volume":"225","author":"Clarenburg","year":"1973","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib56","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.13362","article-title":"Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease","volume":"37","author":"Clarke","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.pharmr.2024.100023_bib57","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41587-022-01354-7","article-title":"Transplantation of a human liver following 3 days of ex situ normothermic preservation","volume":"40","author":"Clavien","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2024.100023_bib58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cpt.2557","article-title":"The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-associated musculoskeletal symptoms","volume":"111","author":"Cooper-DeHoff","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib59","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00228-017-2243-1","article-title":"The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries","volume":"73","author":"Costa","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-019-2634-3","article-title":"Characterization of plasma membrane localization and phosphorylation status of organic anion transporting polypeptide (OATP) 1B1 c.521 T>C nonsynonymous single-nucleotide polymorphism","volume":"36","author":"Crowe","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep.23984","article-title":"Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: studies in Oatp1b2-null mice","volume":"53","author":"Csanaky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib62","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1124\/mol.60.5.934","article-title":"Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2","volume":"60","author":"Cui","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib63","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1074\/jbc.M004968200","article-title":"Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6","volume":"276","author":"Cui","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib64","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10928-015-9437-x","article-title":"Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models","volume":"42","author":"Danhof","year":"2015","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.pharmr.2024.100023_bib65","first-page":"G489","article-title":"Demonstration and modification of intervillous pH profiles in rat small intestine in\u00a0vitro","volume":"257","author":"Daniel","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14622416.2.3.285","article-title":"Pharmacogenetics research network and knowledge base: 1st annual scientific meeting","volume":"2","author":"Davis","year":"2001","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib67","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/17425255.2013.773973","article-title":"Sandwich-cultured hepatocytes: utility for in\u00a0vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity","volume":"9","author":"De Bruyn","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib68","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/jps.22694","article-title":"Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3","volume":"100","author":"De Bruyn","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib69","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2010.07.047","article-title":"Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green","volume":"54","author":"de Graaf","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2967\/jnumed.109.069724","article-title":"(99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy","volume":"51","author":"de Graaf","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6345412","article-title":"Evaluating hepatobiliary transport with (18)F-labeled bile acids: the effect of radiolabel position and bile acid structure on radiosynthesis and in\u00a0vitro and in\u00a0vivo performance","volume":"2018","author":"De Lombaerde","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.pharmr.2024.100023_bib72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/jpet.110.166991","article-title":"Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein","volume":"334","author":"de Waart","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003823","article-title":"The zinc finger SET domain gene Prdm14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32","volume":"3","author":"Dettman","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib74","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/clpt.2012.159","article-title":"Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides","volume":"92","author":"Dolton","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib75","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1478-3231.2005.01158.x","article-title":"Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver","volume":"25","author":"Dransfeld","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.pharmr.2024.100023_bib76","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1021\/acs.chemrev.0c00983","article-title":"Structures and general transport mechanisms by the major facilitator superfamily (MFS)","volume":"121","author":"Drew","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib77","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib78","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.3390\/ijms23147947","article-title":"Protein abundance of drug transporters in human hepatitis C livers","volume":"23","author":"Drozdzik","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib79","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drup.2016.06.005","article-title":"The impact of organic anion-transporting polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice","volume":"27","author":"Durmus","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.pharmr.2024.100023_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722889","article-title":"An overview of cell-based assay platforms for the solute carrier family of transporters","volume":"12","author":"Dvorak","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib81","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1101\/gr.123117.111","article-title":"Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment","volume":"21","author":"Ebeling","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib82","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acs.molpharmaceut.1c00462","article-title":"Non-uniformity of changes in drug-metabolizing enzymes and transporters in liver cirrhosis: implications for drug dosage adjustment","volume":"18","author":"El-Khateeb","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib83","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/liv.14212","article-title":"microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1","volume":"39","author":"El Saadany","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.pharmr.2024.100023_bib84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/17425255.2022.2132932","article-title":"Studying the right transporter at the right time: an in\u00a0vitro strategy for assessing drug-drug interaction risk during drug discovery and development","volume":"18","author":"Elsby","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/pr.111.004614","article-title":"Organic anion transporters and their implications in pharmacotherapy","volume":"64","author":"Emami Riedmaier","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41587-019-0374-x","article-title":"An integrated perfusion machine preserves injured human livers for 1 week","volume":"38","author":"Eshmuminov","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2024.100023_bib87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41575-022-00727-2","article-title":"Long-term dynamic ex\u00a0vivo organ preservation","volume":"20","author":"Eshmuminov","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib88","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.surg.2020.11.042","article-title":"Bile formation in long-term ex situ perfused livers","volume":"169","author":"Eshmuminov","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.pharmr.2024.100023_bib89","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-associated changes in drug transporters may impact the pharmacokinetics and\/or toxicity of drugs: a white paper from the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib90","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/03602530903491683","article-title":"Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects","volume":"42","author":"Fahrmayr","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpba.2018.02.044","article-title":"Quantification of membrane transporter proteins in human lung and immortalized cell lines using targeted quantitative proteomic analysis by isotope dilution nanoLC-MS\/MS","volume":"154","author":"Fallon","year":"2018","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.pharmr.2024.100023_bib92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00498254.2011.626464","article-title":"The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance","volume":"42","author":"Fenner","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmr.2024.100023_bib93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/andp.18551700105","article-title":"Ueber diffusion","volume":"170","author":"Fick","year":"1855","journal-title":"Ann Phys"},{"key":"10.1016\/j.pharmr.2024.100023_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062638","article-title":"Membrane transporters for sulfated steroids in the human testis--cellular localization, expression pattern and functional analysis","volume":"8","author":"Fietz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib95","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/endo.142.5.8115","article-title":"Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner","volume":"142","author":"Fujiwara","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmr.2024.100023_bib96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41573-023-00877-1","article-title":"Membrane transporters in drug development and as determinants of precision medicine","volume":"23","author":"Galetin","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2024.100023_bib97","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)39041-X","article-title":"Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier","volume":"294","author":"Gao","year":"2000","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.exer.2004.08.013","article-title":"Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium","volume":"80","author":"Gao","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib99","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","article-title":"Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS","volume":"467","author":"Gao","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmr.2024.100023_bib100","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41598-024-52904-9","article-title":"Preliminary exploration of hepatic parenchymal near-infrared fluorescence imaging technique via retrograde biliary approach: a feasibility study (with video)","volume":"14","author":"Gao","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib101","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/bib\/bbr042","article-title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium","volume":"12","author":"Gaudet","year":"2011","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.pharmr.2024.100023_bib102","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cpt.1360","article-title":"Clinical aspects of transporter-mediated drug-drug interactions","volume":"105","author":"Gessner","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib103","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11095-008-9597-0","article-title":"Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in\u00a0vitro, pharmacokinetic modeling, and simulation studies","volume":"25","author":"Ghibellini","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib104","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drudis.2021.07.025","article-title":"Positron emission tomographic imaging in drug discovery","volume":"27","author":"Ghosh","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmr.2024.100023_bib105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.clpt.6100056","article-title":"Intestinal drug transporter expression and the impact of grapefruit juice in humans","volume":"81","author":"Glaeser","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib106","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in\u00a0vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib107","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0006-2952(02)01355-2","article-title":"Endogenous drug transporters in in\u00a0vitro and in\u00a0vivo models for the prediction of drug disposition in man","volume":"64","author":"Goh","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib108","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2133\/dmpk.DMPK-12-RV-099","article-title":"Impact of genetic variation in OATP transporters to drug disposition and response","volume":"28","author":"Gong","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib109","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cpt.454","article-title":"Drug transporters: advances and opportunities","volume":"100","author":"Govindarajan","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/FPC.0000000000000512","article-title":"Evaluation of ADRB2 and OATP2A1 genetic polymorphisms in Indian patients with primary open-angle glaucoma","volume":"34","author":"Gowtham","year":"2024","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib111","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.2042-7158.2012.01505.x","article-title":"Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions","volume":"64","author":"Grandvuinet","year":"2012","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib112","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1124\/mol.106.026450","article-title":"Modification of OATP2B1-mediated transport by steroid hormones","volume":"70","author":"Grube","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib113","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1002\/pro.240","article-title":"Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1","volume":"18","author":"Gui","year":"2009","journal-title":"Protein Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib114","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cbpc.2010.01.005","article-title":"Cloning\/characterization of the canine organic anion transporting polypeptide 1b4 (Oatp1b4) and classification of the canine OATP\/SLCO members","volume":"151","author":"Gui","year":"2010","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2008.01.042","article-title":"Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3","volume":"584","author":"Gui","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1875397301004010001","article-title":"Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3","volume":"4","author":"Gui","year":"2010","journal-title":"Curr Chem Genomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib117","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cpt.1183","article-title":"Advancing predictions of tissue and intracellular drug concentrations using in\u00a0vitro, imaging and physiologically based pharmacokinetic modeling approaches","volume":"104","author":"Guo","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib118","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/molpharm.122.000539","article-title":"Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitors","volume":"102","author":"Haberkorn","year":"2022","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj3450115","article-title":"Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X","volume":"345 Pt 1","author":"Hagenbuch","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2024.100023_bib120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmr.2024.100023_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(02)00633-8","article-title":"The superfamily of organic anion transporting polypeptides","volume":"1609","author":"Hagenbuch","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib122","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"issue":"Pt 3","key":"10.1016\/j.pharmr.2024.100023_bib123","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj3160901","article-title":"Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes","volume":"316","author":"Hagenbuch","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2024.100023_bib124","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib125","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1021\/bi00611a016","article-title":"Chloride ion binding to human plasma albumin from chlorine-35 quadrupole relaxation","volume":"17","author":"Halle","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2024.100023_bib126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib127","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bdd.1810","article-title":"Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in\u00a0vitro-in\u00a0vivo extrapolation of oral drug absorption","volume":"34","author":"Harwood","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib128","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1021\/acs.molpharmaceut.3c00108","article-title":"Interlaboratory variability in the madin-darby canine kidney cell proteome","volume":"20","author":"Harwood","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/dmd.121.000748","article-title":"Localization of xenobiotic transporters expressed at the human blood-testis barrier","volume":"50","author":"Hau","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib130","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1158\/1078-0432.CCR-21-0023","article-title":"Regulation of OATP1B1 function by tyrosine kinase-mediated phosphorylation","volume":"27","author":"Hayden","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib131","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1073\/pnas.84.9.2634","article-title":"Expression of size-selected mRNA encoding the intestinal Na\/glucose cotransporter in Xenopus laevis oocytes","volume":"84","author":"Hediger","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib132","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/acs.molpharmaceut.9b01060","article-title":"Measurement of hepatic ABCB1 and ABCG2 transport activity with [(11)C]tariquidar and PET in humans and mice","volume":"17","author":"Hernandez Lozano","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib133","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/nar\/30.1.163","article-title":"PharmGKB: the pharmacogenetics knowledge base","volume":"30","author":"Hewett","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib134","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/jpet.104.068056","article-title":"Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans","volume":"311","author":"Hirano","year":"2004","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib136","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1124\/dmd.106.009290","article-title":"Drug-drug interaction between pitavastatin and various drugs via OATP1B1","volume":"34","author":"Hirano","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib137","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: implications for drug disposition and disease","volume":"78","author":"Ho","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib138","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests: a review","volume":"257","author":"Hoekstra","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.pharmr.2024.100023_bib139","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.bbamem.2015.05.011","article-title":"Protein kinase C affects the internalization and recycling of organic anion transporting polypeptide 1B1","volume":"1848","author":"Hong","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib140","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/acs.molpharmaceut.5b00466","article-title":"Amino acid residues in the putative transmembrane domain 11 of human organic anion transporting polypeptide 1B1 dictate transporter substrate binding, stability, and trafficking","volume":"12","author":"Hong","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib141","doi-asserted-by":"crossref","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","article-title":"A\u00a0novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters","volume":"274","author":"Hsiang","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib142","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1124\/mol.113.085977","article-title":"Conserved tryptophan residues within putative transmembrane domain 6 affect transport function of organic anion transporting polypeptide 1B1","volume":"84","author":"Huang","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib143","doi-asserted-by":"crossref","first-page":"C795","DOI":"10.1152\/ajpcell.00597.2005","article-title":"Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain","volume":"292","author":"Huber","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib144","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5164970","article-title":"Modern diagnostic imaging technique applications and risk factors in the medical field: a review","volume":"2022","author":"Hussain","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.pharmr.2024.100023_bib145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0168-8278(05)80057-1","article-title":"Effect of perfusate pH on the influx of 5-5'-dimethyl-oxazolidine-2,4-dione and dissociation of epidermal growth factor from the cell-surface receptor: the existence of the proton diffusion barrier in the Disse space","volume":"20","author":"Ichikawa","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib146","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajhg.2010.05.012","article-title":"Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13","volume":"87","author":"Isidor","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmr.2024.100023_bib147","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bcpt.13780","article-title":"Drug metabolism and drug transport of the 100 most prescribed oral drugs","volume":"131","author":"Iversen","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib148","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2007.10.041","article-title":"Hepatocyte growth factor increases uptake of estradiol 17beta-D-glucuronide and Oatp1 protein level in rat hepatocytes","volume":"580","author":"Iwakiri","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib149","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1124\/dmd.113.052290","article-title":"Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17beta-glucuronide, estrone-3-sulfate, and sulfobromophthalein","volume":"41","author":"Izumi","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acs.molpharmaceut.5b00664","article-title":"Investigation of fluorescein derivatives as substrates of organic anion transporting polypeptide (OATP) 1B1 to develop sensitive fluorescence-based OATP1B1 inhibition assays","volume":"13","author":"Izumi","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib151","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.xphs.2017.02.012","article-title":"Comparison of the predictability of human hepatic clearance for organic anion transporting polypeptide substrate drugs between different in\u00a0vitro-in\u00a0vivo extrapolation approaches","volume":"106","author":"Izumi","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib152","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/dmd.114.059105","article-title":"Investigation of the impact of substrate selection on in\u00a0vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions","volume":"43","author":"Izumi","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib153","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1172\/JCI115546","article-title":"Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopus laevis oocytes","volume":"88","author":"Jacquemin","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib154","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.91.1.133","article-title":"Expression cloning of a rat liver Na(+)-independent organic anion transporter","volume":"91","author":"Jacquemin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0705922","article-title":"5-HT7 receptor efficacy distribution throughout the canine stomach","volume":"143","author":"Janssen","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib156","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpba.2017.07.023","article-title":"Cell cultures in drug discovery and development: the need of reliable in\u00a0vitro-in\u00a0vivo extrapolation for pharmacodynamics and pharmacokinetics assessment","volume":"147","author":"Jaroch","year":"2018","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.pharmr.2024.100023_bib157","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41597-021-00935-6","article-title":"Chromosomal-scale de novo genome assemblies of cynomolgus macaque and common marmoset","volume":"8","author":"Jayakumar","year":"2021","journal-title":"Sci Data"},{"key":"10.1016\/j.pharmr.2024.100023_bib158","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00726-023-03363-5","article-title":"Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology","volume":"56","author":"Jin","year":"2024","journal-title":"Amino Acids"},{"key":"10.1016\/j.pharmr.2024.100023_bib159","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/tpj.2014.71","article-title":"Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis","volume":"15","author":"Julia","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmr.2024.100023_bib160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2024.100023_bib161","doi-asserted-by":"crossref","first-page":"37206","DOI":"10.1074\/jbc.M103988200","article-title":"Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha","volume":"276","author":"Jung","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib162","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/jhep.2003.50100","article-title":"Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression","volume":"37","author":"Jung","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib163","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/gast.2002.33583","article-title":"Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"122","author":"Jung","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2024.100023_bib164","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cts.12888","article-title":"Coproporphyrin I can serve as an endogenous biomarker for OATP1B1 inhibition: assessment using a glecaprevir\/pibrentasvir clinical study","volume":"14","author":"Kalluri","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib166","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.7754369","article-title":"Identification and characterization of a prostaglandin transporter","volume":"268","author":"Kanai","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2024.100023_bib167","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1124\/dmd.118.080408","article-title":"A\u00a0clinical quantitative evaluation of hepatobiliary transport of [(11)C]dehydropravastatin in humans using positron emission tomography","volume":"46","author":"Kaneko","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib168","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89386.2","article-title":"How accurately can one predict drug binding modes using AlphaFold models?","volume":"12","author":"Karelina","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2024.100023_bib169","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib170","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.xphs.2024.02.012","article-title":"The effects of N-glycosylation on the expression and transport activity of OATP1A2 and OATP2B1","volume":"113","author":"Kataoka","year":"2024","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib171","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11095-018-2493-3","article-title":"Using human plasma as an assay medium in Caco-2 studies improves mass balance for lipophilic compounds","volume":"35","author":"Katneni","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib172","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd2486","article-title":"Defining drug disposition determinants: a pharmacogenetic-pharmacokinetic strategy","volume":"7","author":"Katz","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2024.100023_bib173","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11095-020-02831-x","article-title":"Investigation of fluorescent substrates and substrate-dependent interactions of a drug transporter organic anion transporting polypeptide 2B1 (OATP2B1)","volume":"37","author":"Kawasaki","year":"2020","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib174","first-page":"257","article-title":"Gene expression in mammalian cells and its applications","volume":"3","author":"Khan","year":"2013","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.pharmr.2024.100023_bib175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2024.100023_bib176","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620933741","article-title":"An overview of prevalence, determinants and health outcomes of polypharmacy","volume":"11","author":"Khezrian","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.pharmr.2024.100023_bib177","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/cpt.3062","article-title":"Utilization of OATP1B biomarker coproporphyrin-I to guide drug-drug interaction risk assessment: evaluation by the pharmaceutical industry","volume":"114","author":"Kikuchi","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib178","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/dmd.118.083733","volume":"47","author":"Kim","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib179","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bcpt.12826","article-title":"The effect of genetic polymorphisms in SLCO2B1 on the lipid-lowering efficacy of rosuvastatin in healthy adults with elevated low-density lipoprotein","volume":"121","author":"Kim","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib180","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/cpt.2434","article-title":"Biomarker-informed model-based risk assessment of organic anion transporting polypeptide 1B mediated drug-drug interactions","volume":"111","author":"Kimoto","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib181","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/mp300379q","article-title":"Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes","volume":"9","author":"Kimoto","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib182","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep4.1660","article-title":"Rotor syndrome: glucuronidated bile acidemia from defective reuptake by hepatocytes","volume":"5","author":"Kimura","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib183","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jlcr.3464","article-title":"Radiosynthesis of novel pitavastatin derivative ([(18) F]PTV-F1) as a tracer for hepatic OATP using a one-pot synthetic procedure","volume":"59","author":"Kimura","year":"2016","journal-title":"J\u00a0Labelled Comp Radiopharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib184","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4161\/cbt.11.6.14533","article-title":"Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissue","volume":"11","author":"Kindla","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114534","article-title":"OATP2B1\u2014the underrated member of the organic anion transporting polypeptide family of drug transporters?","volume":"188","author":"Kinzi","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib186","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70041","article-title":"Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe","volume":"17","author":"Kinzi","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib187","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1124\/dmd.124.001686","article-title":"Impact of OATP2B1 on pharmacokinetics of atorvastatin investigated in rSlco2b1-knockout and SLCO2B1-knockin rats","volume":"52","author":"Kinzi","year":"2024","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib188","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1349-7006.2008.00765.x","article-title":"Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia","volume":"99","author":"Kiyotani","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib189","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/tpj.2016.83","article-title":"Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib","volume":"18","author":"Kloth","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmr.2024.100023_bib190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCRESAHA.109.203596","article-title":"Human skeletal muscle drug transporters determine local exposure and toxicity of statins","volume":"106","author":"Knauer","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib191","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.103.051300","article-title":"Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane","volume":"306","author":"Kobayashi","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"91","key":"10.1016\/j.pharmr.2024.100023_bib192","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nucmedbio.2020.09.004","article-title":"[(131)I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [(131)I]MIBG in neuroblastoma","volume":"90","author":"Kobayashi","year":"2020","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib193","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nucmedbio.2014.01.004","article-title":"Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan","volume":"41","author":"Kobayashi","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib194","article-title":"Imaging of hepatic drug transporters with [(131)I]6-beta-iodomethyl-19-norcholesterol","volume":"9","author":"Kobayashi","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib195","doi-asserted-by":"crossref","first-page":"11336","DOI":"10.1074\/jbc.M109.056457","article-title":"Rapid modulation of the organic anion transporting polypeptide 2B1 (OATP2B1, SLCO2B1) function by protein kinase C-mediated internalization","volume":"285","author":"Kock","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib196","doi-asserted-by":"crossref","first-page":"23161","DOI":"10.1074\/jbc.M001448200","article-title":"Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide","volume":"275","author":"Konig","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib197","doi-asserted-by":"crossref","first-page":"G156","DOI":"10.1152\/ajpgi.2000.278.1.G156","article-title":"A\u00a0novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane","volume":"278","author":"Konig","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib198","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects","volume":"65","author":"Konig","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib199","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","author":"Konig","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib200","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/mol.105.014605","article-title":"Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells","volume":"68","author":"Kopplow","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib201","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1002\/jps.21762","article-title":"Analysis of unstirred water layer in in\u00a0vitro permeability experiments","volume":"98","author":"Korjamo","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/17425255.2017.1253679","article-title":"The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions","volume":"13","author":"Kovacsics","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(98)00168-9","article-title":"Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain","volume":"424","author":"Kullak-Ublick","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmr.2024.100023_bib204","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0016-5085(95)90588-X","article-title":"Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver","volume":"109","author":"Kullak-Ublick","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2024.100023_bib205","first-page":"411","article-title":"Functional characterization of the basolateral rat liver organic anion transporting polypeptide","volume":"20","author":"Kullak-Ublick","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib206","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/gast.2001.21176","article-title":"Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver","volume":"120","author":"Kullak-Ublick","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2024.100023_bib207","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pharep.2019.04.001","article-title":"The reference liver\u2014ABC and SLC drug transporters in healthy donor and metastatic livers","volume":"71","author":"Kurzawski","year":"2019","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib208","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1124\/dmd.122.001012","article-title":"The role of coproporphyrins as endogenous biomarkers for organic anion transporting polypeptide 1B inhibition-progress from 2016 to 2023","volume":"51","author":"Lai","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib209","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.116.234914","article-title":"Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition","volume":"358","author":"Lai","year":"2016","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib210","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1021\/acs.molpharmaceut.2c00662","article-title":"Machine learning models identify new inhibitors for human OATP1B1","volume":"19","author":"Lane","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib211","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0006-2952(81)90317-8","article-title":"Two systems are involved in the sulfobromophthalein uptake by rat liver cells: one is shared with bile salts","volume":"30","author":"Laperche","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib212","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41397-020-0166-1","article-title":"Oral absorption of voriconazole is affected by SLCO2B1 c.\u2217396T>C genetic polymorphism in CYP2C19 poor metabolizers","volume":"20","author":"Lee","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmr.2024.100023_bib213","first-page":"13","article-title":"Identification of the gonad-specific anion transporter SLCO6A1 as a cancer\/testis (CT) antigen expressed in human lung cancer","volume":"4","author":"Lee","year":"2004","journal-title":"Cancer Immun"},{"key":"10.1016\/j.pharmr.2024.100023_bib214","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1074\/jbc.M411092200","article-title":"Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry","volume":"280","author":"Lee","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib215","doi-asserted-by":"crossref","first-page":"17349","DOI":"10.1074\/jbc.REV120.009132","article-title":"Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides","volume":"295","author":"Lee","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib216","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.3390\/ijms22168797","article-title":"Organic anion transporting polypeptide 1B1 is a potential reporter for dual MR and optical imaging","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib217","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bcp.15485","article-title":"A\u00a0comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics","volume":"89","author":"Lehtisalo","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib218","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1023\/A:1015888813741","article-title":"Regional jejunal perfusion, a new in\u00a0vivo approach to study oral drug absorption in man","volume":"9","author":"Lennernas","year":"1992","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib219","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/toxsci\/kfj141","article-title":"Molecular characterization and inhibition of amanitin uptake into human hepatocytes","volume":"91","author":"Letschert","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib221","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.fpc.0000114744.08559.92","article-title":"Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)","volume":"14","author":"Letschert","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmr.2024.100023_bib222","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00436.2008","article-title":"Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters","volume":"296","author":"Leuthold","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib223","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/CEG.S64283","article-title":"Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease","volume":"7","author":"Levitt","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.pharmr.2024.100023_bib224","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt196673362","article-title":"Kinetics of pharmacologic effects","volume":"7","author":"Levy","year":"1966","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2007.01.001","article-title":"Human hepatocytes: isolation, cryopreservation and applications in drug development","volume":"168","author":"Li","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharmr.2024.100023_bib226","first-page":"33","article-title":"Human hepatocytes as an effective alternative experimental system for the evaluation of human drug properties: general concepts and assay procedures","volume":"25","author":"Li","year":"2008","journal-title":"Altex"},{"key":"10.1016\/j.pharmr.2024.100023_bib227","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1074\/jbc.273.26.16184","article-title":"Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter","volume":"273","author":"Li","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib228","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/mol.58.2.335","article-title":"Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione","volume":"58","author":"Li","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib229","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s40262-024-01408-w","article-title":"Physiologically based pharmacokinetic model of OATP1B substrates with a nonlinear mixed effect approach: estimating empirical in\u00a0vitro-to-in\u00a0vivo scaling factors","volume":"63","author":"Li","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib230","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.3390\/molecules26185500","article-title":"Endogenous biomarkers for SLC transporter-mediated drug-drug interaction evaluation","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2024.100023_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134748","article-title":"Human organic anion transporting polypeptide 1B3 (OATP1B3) is more heavily N-glycosylated than OATP1B1 in extracellular loops 2 and 5","volume":"278","author":"Liang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharmr.2024.100023_bib232","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-023-00882-7","article-title":"Building a predictive PBPK model for human OATP substrates: a strategic framework for early evaluation of clinical pharmacokinetic variations using pitavastatin as an example","volume":"26","author":"Liang","year":"2024","journal-title":"AAPS J"},{"key":"10.1016\/j.pharmr.2024.100023_bib233","first-page":"1202","article-title":"Applications and limitations of interspecies scaling and in\u00a0vitro extrapolation in pharmacokinetics","volume":"26","author":"Lin","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib234","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41586-021-03742-6","article-title":"Structure of a mammalian sperm cation channel complex","volume":"595","author":"Lin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2024.100023_bib235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature04338","article-title":"Genome sequence, comparative analysis and haplotype structure of the domestic dog","volume":"438","author":"Lindblad-Toh","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2024.100023_bib236","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.abb.2007.07.023","article-title":"Isoforms of alanine aminotransferases in human tissues and serum\u2014differential tissue expression using novel antibodies","volume":"466","author":"Lindblom","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmr.2024.100023_bib237","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib238","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1038\/s41598-017-07012-2","article-title":"Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib239","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.dmpk.2020.07.007","article-title":"Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24","volume":"35","author":"Liu","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib240","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/dmd.112.047910","article-title":"Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2","volume":"41","author":"Liu","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib241","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI118897","article-title":"Cloning, in\u00a0vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT)","volume":"98","author":"Lu","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib242","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/dmd.113.054676","article-title":"The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions","volume":"42","author":"Lundquist","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib243","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.apsb.2019.11.007","article-title":"Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR\/Cas9: a novel model for drug transport and hyperbilirubinemia disease","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.pharmr.2024.100023_bib244","doi-asserted-by":"crossref","first-page":"G271","DOI":"10.1152\/ajpgi.00075.2007","article-title":"Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport","volume":"293","author":"Mahagita","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib245","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/mol.118.114934","article-title":"OATP1B3-1B7 (LST-3TM12) is a drug transporter that affects endoplasmic reticulum access and the metabolism of ezetimibe","volume":"96","author":"Malagnino","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib246","doi-asserted-by":"crossref","first-page":"G751","DOI":"10.1152\/ajpgi.00330.2018","article-title":"OATP1B3-1B7, a novel organic anion transporting polypeptide, is modulated by FXR ligands and transports bile acids","volume":"317","author":"Malagnino","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib247","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcp.2017.12.012","article-title":"LST-3TM12 is a member of the OATP1B family and a functional transporter","volume":"148","author":"Malagnino","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib248","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/cpt.416","article-title":"Imaging transporters: transforming diagnostic and therapeutic development","volume":"100","author":"Mann","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib249","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/dmd.118.081356","article-title":"Drug transporters in xenobiotic disposition and pharmacokinetic prediction","volume":"46","author":"Mao","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib250","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/nprot.2015.128","article-title":"Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens","volume":"10","author":"March","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.pharmr.2024.100023_bib251","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1389200218666170724110818","article-title":"Endogenous biomarkers to assess drug-drug interactions by drug transporters and enzymes","volume":"18","author":"Mariappan","year":"2017","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.pharmr.2024.100023_bib252","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0005-2736(03)00080-4","article-title":"Sensitivity of bile acid transport by organic anion-transporting polypeptides to intracellular pH","volume":"1611","author":"Marin","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116166","article-title":"Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition","volume":"228","author":"Marin","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib254","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2217\/pgs.15.84","article-title":"Polymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination","volume":"16","author":"Mbatchi","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/13816810.2011.628357","article-title":"Lack of association between polymorphisms in the prostaglandin F2alpha receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs","volume":"33","author":"McCarty","year":"2012","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.pharmr.2024.100023_bib256","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1021\/acs.jmedchem.2c01561","article-title":"Development of a suite of gadolinium-free OATP1-targeted paramagnetic probes for liver MRI","volume":"66","author":"McRae","year":"2023","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib257","first-page":"401","article-title":"Basic concepts of pharmacokinetic\/pharmacodynamic (PK\/PD) modelling","volume":"35","author":"Meibohm","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib258","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jps.1167","article-title":"Pharmacokinetic\/pharmacodynamic studies in drug product development","volume":"91","author":"Meibohm","year":"2002","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib259","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbamem.2004.04.004","article-title":"Identification of phalloidin uptake systems of rat and human liver","volume":"1664","author":"Meier-Abt","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib260","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/dmd.106.013342","article-title":"Regional distribution of solute carrier mRNA expression along the human intestinal tract","volume":"35","author":"Meier","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib261","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.23876","article-title":"Liver X receptor alpha and farnesoid X receptor are major transcriptional regulators of OATP1B1","volume":"52","author":"Meyer Zu Schwabedissen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib262","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1158\/0008-5472.CAN-08-0265","article-title":"Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer","volume":"68","author":"Meyer zu Schwabedissen","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib263","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1073\/pnas.0304987101","article-title":"Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney","volume":"101","author":"Mikkaichi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib264","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1600-0676.2000.020004330.x","article-title":"Plasma elimination of cholyl-lysyl-fluorescein (CLF): a pilot study in patients with liver cirrhosis","volume":"20","author":"Milkiewicz","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.pharmr.2024.100023_bib265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1084\/jem.94.5.431","article-title":"The dominant role of the liver in plasma protein synthesis","volume":"94","author":"Miller","year":"1951","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib266","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI115159","article-title":"Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter","volume":"87","author":"Min","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib267","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0026-895X(24)12876-3","article-title":"The thiol sensitivity of glutathione transport in sidedness-sorted basolateral liver plasma membrane and in Oatp1-expressing HeLa cell membrane","volume":"61","author":"Mittur","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib268","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/jpet.108.148411","article-title":"The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide","volume":"329","author":"Miyagawa","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107938","article-title":"Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in\u00a0vitro and in\u00a0vivo","volume":"229","author":"Miyauchi","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib270","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/dmd.123.001285","article-title":"Progress in the quantitative assessment of transporter-mediated drug-drug interactions using endogenous substrates in clinical studies","volume":"51","author":"Mochizuki","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib271","doi-asserted-by":"crossref","first-page":"G424","DOI":"10.1152\/ajpgi.00048.2024","article-title":"Assessing the degree of hepatic ischemia-reperfusion injury using PBPK modeling of sodium fluorescein disposition in ex\u00a0vivo machine-perfused livers","volume":"327","author":"Monti","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib272","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.117.247296","article-title":"Establishing transcriptional signatures to differentiate PXR-, CAR-, and AhR-mediated regulation of drug metabolism and transport genes in cryopreserved human hepatocytes","volume":"365","author":"Moscovitz","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib273","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2091-11-16","article-title":"Review: bilirubin pKa studies: new models and theories indicate high pKa values in water, dimethylformamide and DMSO","volume":"11","author":"Mukerjee","year":"2010","journal-title":"BMC Biochem"},{"key":"10.1016\/j.pharmr.2024.100023_bib274","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/pr.116.013326","article-title":"Biomarkers for in\u00a0vivo assessment of transporter function","volume":"70","author":"Muller","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0009-9236(95)90205-8","article-title":"Application of microdialysis to clinical pharmacokinetics in humans","volume":"57","author":"Muller","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib276","first-page":"55","article-title":"Cellular mechanisms in epithelial transport: advantages and disadvantages of studies with vesicles","volume":"6","author":"Murer","year":"1984","journal-title":"Mol Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib277","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/acs.bioconjchem.5b00495","article-title":"Novel no-wash luminogenic probes for the detection of transporter uptake activity","volume":"27","author":"Mustafa","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib278","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cpt196910122","article-title":"Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin","volume":"10","author":"Nagashima","year":"1969","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib279","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107803","article-title":"Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action","volume":"223","author":"Nakanishi","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2133\/dmpk.DMPK-11-RV-099","article-title":"Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs","volume":"27","author":"Nakanishi","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib281","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.12112061","article-title":"Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging","volume":"264","author":"Nassif","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.pharmr.2024.100023_bib282","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/cpt.2429","article-title":"Performance of plasma coproporphyrin I and III as OATP1B1 biomarkers in humans","volume":"110","author":"Neuvonen","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib283","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.nucmedbio.2016.07.001","article-title":"Synthesis, in\u00a0vitro and in\u00a0vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function","volume":"43","author":"Neyt","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2021.183554","article-title":"Leucine heptad motifs within transmembrane domains affect function and oligomerization of human organic anion transporting polypeptide 1B1","volume":"1863","author":"Ni","year":"2021","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.pharmr.2024.100023_bib285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib286","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm405","article-title":"Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1","volume":"5","author":"Nies","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108268","article-title":"Hepatic solute carrier transporters and drug therapy: regulation of expression and impact of genetic variation","volume":"238","author":"Nies","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib288","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.3377","article-title":"Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate","volume":"275","author":"Nishio","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib289","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.119.088922","article-title":"Organic anion-transporting polypeptide genes are not induced by the pregnane X receptor activator rifampin: studies in hepatocytes in\u00a0vitro and in monkeys in\u00a0vivo","volume":"47","author":"Niu","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib290","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1073\/pnas.94.19.10346","article-title":"Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain","volume":"94","author":"Noe","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib291","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1124\/dmd.106.012930","article-title":"Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3","volume":"35","author":"Noe","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib292","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1073\/pnas.2010264117","article-title":"Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1","volume":"117","author":"Nosol","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib293","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.103.060194","article-title":"Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human","volume":"308","author":"Nozawa","year":"2004","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib294","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-pharmtox-010510-100556","article-title":"The expression and function of organic anion transporting polypeptides in normal tissues and in cancer","volume":"52","author":"Obaidat","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib295","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/bbrc.2000.2830","article-title":"Full-length cDNA cloning and genomic organization of the mouse liver-specific organic anion transporter-1 (lst-1)","volume":"272","author":"Ogura","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib296","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.111.042259","article-title":"Simultaneous absolute protein quantification of transporters, cytochrome P450s and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities","volume":"40","author":"Ohtsuki","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib297","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.devcel.2018.09.012","article-title":"A\u00a0membrane transporter is required for steroid hormone uptake in Drosophila","volume":"47","author":"Okamoto","year":"2018","journal-title":"Dev Cell"},{"key":"10.1016\/j.pharmr.2024.100023_bib298","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/dnares\/11.3.205","article-title":"Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries","volume":"11","author":"Okazaki","year":"2004","journal-title":"DNA Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib299","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2007-1007167","article-title":"Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine","volume":"18","author":"Ookhtens","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.pharmr.2024.100023_bib300","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/molbev\/msi187","article-title":"Substitution rate and structural divergence of 5'UTR evolution: comparative analysis between human and cynomolgus monkey cDNAs","volume":"22","author":"Osada","year":"2005","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmr.2024.100023_bib301","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pharmthera.2018.10.007","article-title":"Organic anion transporting polypeptide (OATP) transporter expression, localization and function in the human intestine","volume":"195","author":"Oswald","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib302","first-page":"S162","article-title":"Sex differences in membrane binding and hepatic transport of indocyanine green (ICG) in rat liver","volume":"23","author":"Ott","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib303","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/03602532.2024.2386597","article-title":"Mechanisms of intestinal pharmacokinetic natural product-drug interactions","volume":"56","author":"Oyanna","year":"2024","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib304","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115448","article-title":"Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox","volume":"209","author":"Ozvegy-Laczka","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib305","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1053\/j.gastro.2018.07.031","article-title":"Solute carrier organic anion transporter family member 3A1 is a bile acid efflux transporter in cholestasis","volume":"155","author":"Pan","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2024.100023_bib306","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/dmd.113.055707","article-title":"The role of organic anion transporters in diagnosing liver diseases by magnetic resonance imaging","volume":"42","author":"Pastor","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib307","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2015.09.015","article-title":"Functional expression of the 11 human organic anion transporting polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate","volume":"98","author":"Patik","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib308","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/s41598-018-20815-1","article-title":"Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of organic anion-transporting polypeptides, OATP1B1\/1B3 and 2B1","volume":"8","author":"Patik","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib309","first-page":"1","article-title":"The handling of indocyanine green by the liver","volume":"105","author":"Paumgartner","year":"1975","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.pharmr.2024.100023_bib310","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0168-8278(88)80052-7","article-title":"Sex steroid modulation of the hepatic uptake of organic anions in rat","volume":"6","author":"Persico","year":"1988","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib311","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BFb0030903","article-title":"Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport","volume":"123","author":"Petzinger","year":"1994","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib312","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/me.2001-0309","article-title":"Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter","volume":"16","author":"Pizzagalli","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmr.2024.100023_bib313","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jc.2003-030174","article-title":"Identification of steroid sulfate transport processes in the human mammary gland","volume":"88","author":"Pizzagalli","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2024.100023_bib314","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0005-2736(87)90034-4","article-title":"The kinetics of sulfobromophthalein uptake by rat liver sinusoidal vesicles","volume":"898","author":"Potter","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib315","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.1840200441","article-title":"Induction of a dose-related increase in sulfobromophthalein uptake velocity in freshly isolated rat hepatocytes by phenobarbital","volume":"20","author":"Potter","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib316","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/pharmaceutics16010063","article-title":"Assessing trans-inhibition of OATP1B1 and OATP1B3 by calcineurin and\/or PPIase inhibitors and global identification of OATP1B1\/3-associated proteins","volume":"16","author":"Powell","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2024.100023_bib317","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/dmd.113.053819","article-title":"Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex","volume":"42","author":"Prasad","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib318","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt.409","article-title":"Ontogeny of hepatic drug transporters as quantified by LC-MS\/MS proteomics","volume":"100","author":"Prasad","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib319","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2125.1988.tb03318.x","article-title":"Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)","volume":"25","author":"Prentis","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020372","article-title":"Expression of OATP family members in hormone-related cancers: potential markers of progression","volume":"6","author":"Pressler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib321","series-title":"Principles of Clinical Pharmacology","first-page":"197","article-title":"Equlibrative and concentrative transport mechanisms","author":"Preusch","year":"2007"},{"key":"10.1016\/j.pharmr.2024.100023_bib322","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1208\/s12248-013-9470-x","article-title":"Drug-drug interaction studies: regulatory guidance and an industry perspective","volume":"15","author":"Prueksaritanont","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.pharmr.2024.100023_bib323","first-page":"R734","article-title":"Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities","volume":"277","author":"Pucci","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib324","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.copbio.2021.05.001","article-title":"Molecular characterization of HEK293 cells as emerging versatile cell factories","volume":"71","author":"Pulix","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.pharmr.2024.100023_bib325","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03602532.2012.756010","article-title":"Primary hepatocyte cultures as prominent in\u00a0vitro tools to study hepatic drug transporters","volume":"45","author":"Ramboer","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib326","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt.2705","article-title":"PharmVar GeneFocus: SLCO1B1","volume":"113","author":"Ramsey","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.pharmr.2024.100023_bib327","first-page":"S9","article-title":"The receptor concept: pharmacology\u2019s big idea","volume":"147","author":"Rang","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib328","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MNM.0000000000000973","article-title":"Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function","volume":"40","author":"Rassam","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib329","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.119.089615","article-title":"Induction of human intestinal and hepatic organic anion transporting polypeptides: where is the evidence for its relevance in drug-drug interactions?","volume":"48","author":"Rodrigues","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib330","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1124\/dmd.123.001587","article-title":"Survey of pharmaceutical industry's best practices around in\u00a0vitro transporter assessment and implications for drug development: considerations from the IQ Transporter Working Group","volume":"52","author":"Rollison","year":"2024","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib331","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0076-6879(98)96004-9","article-title":"Expression cloning using Xenopus laevis oocytes","volume":"296","author":"Romero","year":"1998","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharmr.2024.100023_bib332","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41525-023-00370-z","article-title":"SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy","volume":"8","author":"Roshandel","year":"2023","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib333","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/clpt.2012.65","article-title":"Physiologically based pharmacokinetics joined with in\u00a0vitro-in\u00a0vivo extrapolation of ADME: a marriage under the arch of systems pharmacology","volume":"92","author":"Rostami-Hodjegan","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib334","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd2173","article-title":"Simulation and prediction of in\u00a0vivo drug metabolism in human populations from in\u00a0vitro data","volume":"6","author":"Rostami-Hodjegan","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2024.100023_bib335","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib336","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/dmd.110.036640","article-title":"Interactions of green tea catechins with organic anion-transporting polypeptides","volume":"39","author":"Roth","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib337","first-page":"378","article-title":"An experimental and clinical study of theHediger value of pheholtetrachlophthalein as a test for hepatic function","volume":"24","author":"Rowntree","year":"1913","journal-title":"Johns Hopkins Hosp Bull"},{"key":"10.1016\/j.pharmr.2024.100023_bib338","first-page":"1","article-title":"Transporter-mediated drug-drug interactions: regulatory guidelines, in\u00a0vitro and in\u00a0vivo methodologies and translation, special populations, and the blood-brain barrier","author":"Russell","year":"2024","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib339","doi-asserted-by":"crossref","first-page":"20719","DOI":"10.1074\/jbc.271.34.20719","article-title":"Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney","volume":"271","author":"Saito","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib340","first-page":"207","article-title":"Assessing liver function","volume":"13","author":"Sakka","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.pharmr.2024.100023_bib341","doi-asserted-by":"crossref","first-page":"1028S","DOI":"10.1093\/ajcn\/69.5.1028s","article-title":"The physicochemical environment of the neonatal intestine","volume":"69","author":"Sanderson","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmr.2024.100023_bib342","article-title":"Real-world application of PBPK in drug discovery","author":"Santos","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib343","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1074\/jbc.272.42.26340","article-title":"Organic anion transporting polypeptide mediates organic anion\/HCO3- exchange","volume":"272","author":"Satlin","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib344","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/pharmaceutics15020497","article-title":"Biological distribution after oral administration of radioiodine-labeled acetaminophen to estimate gastrointestinal absorption function via OATPs, OATs, and\/or MRPs","volume":"15","author":"Sato","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2024.100023_bib345","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/membranes13050462","article-title":"Ins and outs of rocker switch mechanism in major facilitator superfamily of transporters","volume":"13","author":"Sauve","year":"2023","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.pharmr.2024.100023_bib346","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105920","article-title":"How good are AlphaFold models for docking-based virtual screening?","volume":"26","author":"Scardino","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.pharmr.2024.100023_bib347","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-024-01570-z","article-title":"Big data and benchmarking initiatives to bridge the gap from AlphaFold to drug design","volume":"20","author":"Schapira","year":"2024","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib348","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI108204","article-title":"Hepatic organic anion uptake in the rat","volume":"56","author":"Scharschmidt","year":"1975","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib349","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/00498254.2013.815831","article-title":"Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications","volume":"44","author":"Scheer","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmr.2024.100023_bib350","first-page":"598","article-title":"Bericht \u00fcber einige Versuchsreihen, angestellt im physiol. Laboratorium des Instituts zu Florenz. I. Gallenbildung, abh\u00e4ngig von der Aufsaugung der Gallestoffe","volume":"3","author":"Schiff","year":"1870","journal-title":"Archiv f\u00fcr die gesamte Physiologie des Menschen und der Tiere"},{"key":"10.1016\/j.pharmr.2024.100023_bib351","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ddtec.2005.01.001","article-title":"Physiology-based pharmacokinetic modeling: ready to be used","volume":"2","author":"Schmitt","year":"2005","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.pharmr.2024.100023_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101824","article-title":"Sodium taurocholate co-transporting polypeptide deficiency","volume":"46","author":"Schneider","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.pharmr.2024.100023_bib353","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/mol.118.114314","article-title":"Organic anion transporting polypeptides: emerging roles in cancer pharmacology","volume":"95","author":"Schulte","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib354","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/03602532.2023.2195133","article-title":"Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review","volume":"55","author":"Schulz","year":"2023","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib355","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/FPC.0b013e328342f5b1","article-title":"Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity","volume":"21","author":"Schwarz","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib356","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1432-1033.1976.tb10287.x","article-title":"Uptakeof bromosulfophthalein by isolated liver cells","volume":"64","author":"Schwenk","year":"1976","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmr.2024.100023_bib357","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/j.1552-4604.1988.tb05745.x","article-title":"Basic concepts in pharmaco-dynamic modeling","volume":"28","author":"Schwinghammer","year":"1988","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib358","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083257","article-title":"Characterization of SLCO5A1\/OATP5A1, a solute carrier transport protein with non-classical function","volume":"8","author":"Sebastian","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib359","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkad232","article-title":"Whole genome assembly and annotation of the endangered Caribbean coral Acropora cervicornis","volume":"13","author":"Selwyn","year":"2023","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.pharmr.2024.100023_bib360","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41422-023-00870-8","article-title":"Cryo-EM structures of human organic anion transporting polypeptide OATP1B1","volume":"33","author":"Shan","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib361","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/dmd.118.081125","article-title":"Further studies to support the use of coproporphyrin I and III as novel clinical biomarkers for evaluating the potential for organic anion transporting polypeptide 1B1 and OATP1B3 inhibition","volume":"46","author":"Shen","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib362","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.116.232066","article-title":"Coproporphyrins I and III as functional markers of OATP1B activity: in\u00a0vitro and in\u00a0vivo evaluation in preclinical species","volume":"357","author":"Shen","year":"2016","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib363","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.112.200691","article-title":"Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in\u00a0vitro, in\u00a0vivo, and in\u00a0vitro-to-in\u00a0vivo extrapolation","volume":"344","author":"Shen","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib364","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/cts.12582","article-title":"Design and conduct considerations for first-in-human trials","volume":"12","author":"Shen","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib365","doi-asserted-by":"crossref","first-page":"25591","DOI":"10.1074\/jbc.270.43.25591","article-title":"Stable inducible expression of a functional rat liver organic anion transport protein in HeLa cells","volume":"270","author":"Shi","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib366","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2133\/dmpk.DMPK-11-SH-080","article-title":"Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites","volume":"27","author":"Shirasaka","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib367","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.108.025544","article-title":"Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats","volume":"37","author":"Shitara","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib368","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.DMPK-11-RG-096","article-title":"Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake","volume":"27","author":"Shitara","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib369","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1016\/S0021-9258(18)53136-7","article-title":"Characterization of endogenous carrier-mediated taurocholate efflux from Xenopus laevis oocytes","volume":"268","author":"Shneider","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4939-0956-8_6","article-title":"Pharmacogenetics of membrane transporters: a review of current approaches","volume":"1175","author":"Sissung","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib371","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/pgs.16.16","article-title":"Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort","volume":"17","author":"Smith","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmr.2024.100023_bib372","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0168-8278(96)80071-7","article-title":"Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity\/low capacity sinusoidal membrane system","volume":"25","author":"Sorrentino","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pharmr.2024.100023_bib373","first-page":"G425","article-title":"Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration","volume":"266","author":"Sorrentino","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib374","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkad192","article-title":"Whole genome sequence of the deep-sea sponge Geodia barretti (Metazoa, Porifera, Demospongiae)","volume":"13","author":"Steffen","year":"2023","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.pharmr.2024.100023_bib375","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2533\/chimia.2022.1025","article-title":"Transporters for bile formation in physiology and pathophysiology","volume":"76","author":"Stieger","year":"2022","journal-title":"Chimia (Aarau)"},{"key":"10.1016\/j.pharmr.2024.100023_bib376","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-800223-0.00005-0","article-title":"Organic anion-transporting polypeptides","volume":"73","author":"Stieger","year":"2014","journal-title":"Curr Top Membr"},{"key":"10.1016\/j.pharmr.2024.100023_bib377","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.11.048","article-title":"The emerging role of transport systems in liver function tests","volume":"675","author":"Stieger","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib378","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev-pharmtox-010716-105010","article-title":"Intestinal and hepatocellular transporters: therapeutic effects and drug interactions of herbal supplements","volume":"57","author":"Stieger","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib379","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166079","article-title":"Membrane lipids and transporter function","volume":"1867","author":"Stieger","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.pharmr.2024.100023_bib380","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1172\/JCI112646","article-title":"Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein\/bilirubin binding protein","volume":"78","author":"Stremmel","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib381","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169719","article-title":"Preference of conjugated bile acids over unconjugated bile acids as substrates for OATP1B1 and OATP1B3","volume":"12","author":"Suga","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib382","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/dmd.30.2.220","article-title":"Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates","volume":"30","author":"Sugiyama","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib383","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/dmd.123.001344","article-title":"A\u00a020-year research overview: quantitative prediction of hepatic clearance using the in\u00a0vitro-in\u00a0vivo extrapolation approach based on physiologically based pharmacokinetic modeling and extended clearance concept","volume":"51","author":"Sugiyama","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib384","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11095-007-9399-9","article-title":"Membrane trafficking of the human organic anion-transporting polypeptide C (hOATPC)","volume":"25","author":"Sun","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106838","article-title":"Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration","volume":"200","author":"Sun","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib386","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1111\/febs.17255","article-title":"Transport of aromatic amino acids l-tryptophan, l-tyrosine, and l-phenylalanine by the organic anion transporting polypeptide (OATP) 3A1","volume":"291","author":"Surrer","year":"2024","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2024.100023_bib387","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/me.2002-0304","article-title":"Identification and characterization of novel rat and human gonad-specific organic anion transporters","volume":"17","author":"Suzuki","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmr.2024.100023_bib388","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopha.2011.04.031","article-title":"Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport","volume":"65","author":"Svoboda","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2024.100023_bib389","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in\u00a0vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105395","article-title":"Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions","volume":"151","author":"Szekely","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib391","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213747","article-title":"The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine","volume":"14","author":"Taghikhani","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib392","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00726-020-02867-8","article-title":"Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells","volume":"52","author":"Taghikhani","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.pharmr.2024.100023_bib393","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41397-019-0086-0","article-title":"Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid","volume":"20","author":"Tague","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmr.2024.100023_bib394","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/acs.molpharmaceut.0c00193","article-title":"Regulation of organic anion transporting polypeptide 2B1 expression by MicroRNA in the human liver","volume":"17","author":"Tajiri","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib395","first-page":"241","article-title":"Contribution of OATPs to drug absorption in human intestine is much less than predicted","volume":"45","author":"Takada","year":"2014","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib396","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2967\/jnumed.111.098681","article-title":"PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me","volume":"53","author":"Takashima","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib397","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2967\/jnumed.112.110254","article-title":"Evaluation of breast cancer resistance protein function in hepatobiliary and renal excretion using PET with 11C-SC-62807","volume":"54","author":"Takashima","year":"2013","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib398","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.addr.2011.07.007","article-title":"Oral drug delivery utilizing intestinal OATP transporters","volume":"64","author":"Tamai","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib399","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.2000.2922","article-title":"Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family","volume":"273","author":"Tamai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib400","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1023\/A:1013077609227","article-title":"Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C","volume":"18","author":"Tamai","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib401","article-title":"Genetic alteration of SLCO1B3 defines constitutional indocyanine green excretory defect in patients who underwent hepatectomy","author":"Tanimoto","year":"2024","journal-title":"Hepatol Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib402","first-page":"281","article-title":"Ueber die Aufsaugung der gallensauren Alkalien im D\u00fcnndarme","volume":"77","author":"Tappeiner","year":"1878","journal-title":"Sitzungsber Kais Akad Wissensch Wien"},{"key":"10.1016\/j.pharmr.2024.100023_bib403","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/cpt.1693","article-title":"Physiologically-based pharmacokinetic models for evaluating membrane transporter mediated drug-drug interactions: current capabilities, case studies, future opportunities, and recommendations","volume":"107","author":"Taskar","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib404","first-page":"205","article-title":"Studies on the diffusion effect upon ionic distribution: I. The extrvascular modes of administratin","volume":"57","author":"Teorell","year":"1937","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib405","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41592-023-02087-4","article-title":"AlphaFold predictions are valuable hypotheses and accelerate but do not replace experimental structure determination","volume":"21","author":"Terwilliger","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.pharmr.2024.100023_bib406","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bmc.2016.12.008","article-title":"Design, synthesis, in\u00a0vitro characterization and preliminary imaging studies on fluorinated bile acid derivatives as PET tracers to study hepatic transporters","volume":"25","author":"Testa","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib407","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/mp3005353","article-title":"A\u00a0cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells","volume":"10","author":"Thakkar","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib408","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.xphs.2017.04.053","article-title":"Effect of liver disease on hepatic transporter expression and function","volume":"106","author":"Thakkar","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib409","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.pharmr.2024.100023_bib410","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmr.2024.100023_bib411","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-5193(77)90357-5","article-title":"Derivation of the equations that describe the effects of unstirred water layers on the kinetic parameters of active transport processes in the intestine","volume":"64","author":"Thomson","year":"1977","journal-title":"J\u00a0Theor Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib412","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ddtec.2021.02.003","article-title":"Recent advances in CHO cell line development for recombinant protein production","volume":"38","author":"Tihanyi","year":"2020","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.pharmr.2024.100023_bib413","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0304-4157(90)90012-2","article-title":"Biochemical and molecular aspects of the hepatic uptake of organic anions","volume":"1031","author":"Tiribelli","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib414","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib415","first-page":"465","article-title":"Hepatic clearance models: comparison of the dispersion and Goresky models in outflow profiles from multiple indicator dilution rat liver studies","volume":"26","author":"Tirona","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib416","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1210\/en.2004-0058","article-title":"Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier","volume":"145","author":"Tohyama","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmr.2024.100023_bib417","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1073\/pnas.90.17.8136","article-title":"Bilitranslocase and sulfobromophthalein\/bilirubin-binding protein are both involved in the hepatic uptake of organic anions","volume":"90","author":"Torres","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib418","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2018.04.006","article-title":"Imaging techniques to study drug transporter function in\u00a0vivo","volume":"189","author":"Tournier","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib419","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1681\/ASN.2009070696","article-title":"SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation","volume":"20","author":"Toyohara","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pharmr.2024.100023_bib420","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1124\/dmd.106.013615","article-title":"Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil","volume":"35","author":"Treiber","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib421","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1021\/acs.jcim.8b00466","article-title":"Integrative data mining, scaffold analysis, and sequential binary classification models for exploring ligand profiles of hepatic organic anion transporting polypeptides","volume":"59","author":"T\u00fcrkova","year":"2019","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.pharmr.2024.100023_bib422","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300530RR","article-title":"The fluorescence-based competitive counterflow assay developed for organic anion transporting polypeptides 1A2, 1B1, 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate","volume":"37","author":"Ungvari","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2024.100023_bib423","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100648R","article-title":"8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1","volume":"35","author":"Ungvari","year":"2021","journal-title":"FASEB J"},{"issue":"Suppl 7","key":"10.1016\/j.pharmr.2024.100023_bib424","first-page":"S59","article-title":"Comparing various in\u00a0vitro prediction criteria to assess the potential of a new molecular entity to inhibit organic anion transporting polypeptide 1B1","volume":"56","author":"Vaidyanathan","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib425","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-291X(76)90529-5","article-title":"Bromsulfophthalein uptake by isolated liver parenchymal cells","volume":"69","author":"van Bezooijen","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2024.100023_bib426","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib427","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib428","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejps.2018.08.042","article-title":"Proteomics of human liver membrane transporters: a focus on fetuses and newborn infants","volume":"124","author":"van Groen","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib429","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0005-2736(02)00445-5","article-title":"Functional characterization of the mouse organic-anion-transporting polypeptide 2","volume":"1564","author":"van Montfoort","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib430","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1","volume":"290","author":"van Montfoort","year":"1999","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib431","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/mp200103h","article-title":"pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1","volume":"8","author":"Varma","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmr.2024.100023_bib432","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mam.2017.03.003","article-title":"Bile acid analysis in human disorders of bile acid biosynthesis","volume":"56","author":"Vaz","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib433","article-title":"Computational chemical analysis of unconjugated bilirubin anions and insights into pKa values clarification","volume":"138","author":"Vega-Hissi","year":"2013","journal-title":"J\u00a0Chem Phys"},{"key":"10.1016\/j.pharmr.2024.100023_bib434","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1124\/dmd.113.056309","article-title":"Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactions","volume":"42","author":"Vildhede","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib435","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cpt.1699","article-title":"Quantitative proteomics and mechanistic modeling of transporter-mediated disposition in nonalcoholic fatty liver disease","volume":"107","author":"Vildhede","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib436","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1139\/y96-148","article-title":"Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver","volume":"74","author":"Villeneuve","year":"1996","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib437","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.510230104","article-title":"The hepatic microcirculation in the isolated perfused human liver","volume":"23","author":"Villeneuve","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2024.100023_bib438","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/mol.111.074823","article-title":"Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1)","volume":"81","author":"Visentin","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib439","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/17460441.2024.2387790","article-title":"Application of transporter assays for drug discovery and development: an update of the literature","volume":"19","author":"Volpe","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharmr.2024.100023_bib440","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1124\/dmd.120.000122","article-title":"Functional consequences of pravastatin isomerization on OATP1B1-mediated transport","volume":"48","author":"Wagner","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib441","doi-asserted-by":"crossref","first-page":"G1188","DOI":"10.1152\/ajpgi.2000.279.6.G1188","article-title":"Expression, transport properties, and chromosomal location of organic anion transporter subtype 3","volume":"279","author":"Walters","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib442","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s11033-020-05361-2","article-title":"Biological barriers, and the influence of protein binding on the passage of drugs across them","volume":"47","author":"Wanat","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharmr.2024.100023_bib443","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00404-011-2183-4","article-title":"Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy","volume":"285","author":"Wang","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.pharmr.2024.100023_bib444","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.pbio.0050013","article-title":"Rate of evolution in brain-expressed genes in humans and other primates","volume":"5","author":"Wang","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib445","article-title":"Association between SLCO1A2 genetic variation and methotrexate toxicity in human rheumatoid arthritis treatment","volume":"34","author":"Wang","year":"2020","journal-title":"J\u00a0Biochem Mol Toxicol"},{"key":"10.1016\/j.pharmr.2024.100023_bib446","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jchromb.2017.07.051","article-title":"Development of a rapid and sensitive multiple reaction monitoring proteomic approach for quantification of transporters in human liver tissue","volume":"1061\u20131062","author":"Wang","year":"2017","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib447","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1124\/dmd.123.001248","article-title":"Interaction of human OATP1B1 with PDZK1 is required for its trafficking to the hepatocyte plasma membrane","volume":"51","author":"Wang","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib448","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.leukres.2018.01.004","article-title":"Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia","volume":"65","author":"Wang","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib449","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12893-024-02411-5","article-title":"Clinical application of indocyanine green fluorescence navigation technique in laparoscopic common bile duct exploration for complex hepatolithiasis","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Surg"},{"key":"10.1016\/j.pharmr.2024.100023_bib450","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1124\/dmd.105.005926","article-title":"Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators","volume":"33","author":"Wang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib451","doi-asserted-by":"crossref","first-page":"35844","DOI":"10.1021\/acsomega.1c06163","article-title":"Human organic anion transporting polypeptides 1B1, 1B3, and 2B1 are involved in the hepatic uptake of phenolsulfonphthalein","volume":"6","author":"Wang","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.pharmr.2024.100023_bib452","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1124\/dmd.124.001878","article-title":"Characterization and prediction of OATP1B activity in prostate cancer patients on abiraterone acetate using endogenous biomarker coproporphyrin I","volume":"52","author":"Wang","year":"2024","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib453","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI89812","article-title":"Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia","volume":"127","author":"Ware","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib454","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2024.100023_bib455","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/dmd.109.030254","article-title":"Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib456","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/cpt.2056","article-title":"Proteomics-informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight","volume":"109","author":"Wegler","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib457","first-page":"G922","article-title":"Free concentrations of intracellular fluorescent anions determined by cytoplasmic dialysis of isolated hepatocytes","volume":"267","author":"Weinman","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib458","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1073\/pnas.82.5.1563","article-title":"Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver","volume":"82","author":"Weisiger","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2024.100023_bib459","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0005-2795(80)90123-3","article-title":"The role of albumin conformation in the binding of diazepam to human serum albumin","volume":"626","author":"Wilting","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib460","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1016\/S0021-9258(19)85847-7","volume":"255","author":"Wilting","year":"1980","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib461","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/en.2014-1830","article-title":"Parallel regulation of thyroid hormone transporters OATP1c1 and MCT8 during and after endotoxemia at the blood-brain barrier of male rodents","volume":"156","author":"Wittmann","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmr.2024.100023_bib462","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.113.051037","article-title":"Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin","volume":"41","author":"Wlcek","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib463","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pds.5310","article-title":"Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry","volume":"30","author":"Wolff","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.pharmr.2024.100023_bib464","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1172\/JCI112946","article-title":"Influence of Cl- on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver","volume":"79","author":"Wolkoff","year":"1987","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pharmr.2024.100023_bib465","doi-asserted-by":"crossref","first-page":"27228","DOI":"10.1074\/jbc.270.45.27228","article-title":"Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity","volume":"270","author":"Wong","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib466","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387787-1.00007-6","article-title":"Deep phylogeny and evolution of sponges (phylum Porifera)","volume":"61","author":"Worheide","year":"2012","journal-title":"Adv Mar Biol"},{"key":"10.1016\/j.pharmr.2024.100023_bib467","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1055-9965.EPI-10-1023","article-title":"Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes","volume":"20","author":"Wright","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pharmr.2024.100023_bib468","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mrm.27749","article-title":"In\u00a0vivo imaging of insulin-secreting human pancreatic ductal cells using MRI reporter gene technique: a feasibility study","volume":"82","author":"Wu","year":"2019","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.pharmr.2024.100023_bib469","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1080\/00498254.2020.1777484","article-title":"LncRNA HOTAIR modulates the expression of OATP1B1 in HepG2 cells by sponging miR-206\/miR-613","volume":"50","author":"Xu","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmr.2024.100023_bib470","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1124\/dmd.122.000882","article-title":"Isotretinoin and its metabolites alter mRNA of multiple enzyme and transporter genes in\u00a0vitro, but downregulation of organic anion transporting polypeptide does not translate to the clinic","volume":"50","author":"Yadav","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib471","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2133\/dmpk.25.314","article-title":"Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1","volume":"25","author":"Yamaguchi","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharmr.2024.100023_bib472","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/clpt.2011.102","article-title":"Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia","volume":"90","author":"Yamakawa","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib473","first-page":"1","article-title":"Ecdysteroid signalling in insects\u2014from biosynthesis to gene expression regulation","volume":"60","author":"Yamanaka","year":"2021","journal-title":"Adv Insect Physiol"},{"key":"10.1016\/j.pharmr.2024.100023_bib474","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.xphs.2015.11.008","article-title":"Sandwich-cultured hepatocytes as a tool to study drug disposition and drug-induced liver injury","volume":"105","author":"Yang","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052563","article-title":"N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib476","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bmc.2004.10.009","article-title":"Application of QSAR analysis to organic anion transporting polypeptide 1a5 (Oatp1a5) substrates","volume":"13","author":"Yarim","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmr.2024.100023_bib477","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/cts.12625","article-title":"Organic anion transporter polypeptide 1B1 polymorphism modulates the extent of drug-drug interaction and associated biomarker levels in healthy volunteers","volume":"12","author":"Yee","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib478","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cpt.434","article-title":"Metaboloimc and genome-wide association studies reveal potential endogenous biomarkers vor OATP1B1","volume":"100","author":"Yee","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib479","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/clpt.2011.351","article-title":"Transporter-mediated drug--drug interactions involving OATP substrates: predictions based on in\u00a0vitro inhibition studies","volume":"91","author":"Yoshida","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib480","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/pharmrev.120.000238","article-title":"Organotypic and microphysiological human tissue models for drug discovery and development-current state-of-the-art and future perspectives","volume":"74","author":"Youhanna","year":"2022","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib481","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.xphs.2020.07.001","article-title":"The past, present and future of intestinal in\u00a0vitro cell systems for drug absorption studies","volume":"110","author":"Youhanna","year":"2021","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib482","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.xphs.2017.04.004","article-title":"Intestinal drug interactions mediated by OATPs: a systematic review of preclinical and clinical findings","volume":"106","author":"Yu","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pharmr.2024.100023_bib483","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/clpt.2013.45","article-title":"ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans","volume":"94","author":"Zamek-Gliszczynski","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2024.100023_bib484","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/dmd.119.086744","article-title":"Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities","volume":"47","author":"Zhang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib485","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3109\/02713683.2016.1143013","article-title":"PTGFR and SLCO2A1 gene polymorphisms determine intraocular pressure response to latanoprost in Han Chinese patients with glaucoma","volume":"41","author":"Zhang","year":"2016","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.pharmr.2024.100023_bib486","article-title":"Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2024.100023_bib487","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1124\/dmd.119.089847","article-title":"OATP1B3 expression and function is modulated by coexpression with OCT1, OATP1B1, and NTCP","volume":"48","author":"Zhang","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmr.2024.100023_bib488","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1476-5381.2010.01144.x","article-title":"Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2","volume":"162","author":"Zhou","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2024.100023_bib489","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1208\/s12248-013-9515-1","article-title":"Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2","volume":"15","author":"Zhou","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.pharmr.2024.100023_bib490","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.addr.2016.06.004","article-title":"Recent advance in the pharmacogenomics of human solute carrier transporters (SLCs) in drug disposition","volume":"116","author":"Zhou","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmr.2024.100023_bib491","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000381313","article-title":"Genetic polymorphisms and function of the organic anion-transporting polypeptide 1A2 and its clinical relevance in drug disposition","volume":"95","author":"Zhou","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmr.2024.100023_bib492","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0167-4889(94)90226-7","article-title":"The transporter for the HMG-CoA reductase inhibitor pravastatin is not present in Hep G2 cells. Evidence for the nonidentity of the carrier for pravastatin and certain transport systems for BSP","volume":"1223","author":"Ziegler","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2024.100023_bib493","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1745-6150-9-20","article-title":"A\u00a0new rhesus macaque assembly and annotation for next-generation sequencing analyses","volume":"9","author":"Zimin","year":"2014","journal-title":"Biol Direct"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724126233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724126233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:48:13Z","timestamp":1778705293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724126233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":493,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0031699724126233"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2024.100023","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2024.100023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100023"}}